Credit: Shutterstock / Studio Romantic Emalex Biosciences is eyeing approval for its Tourette syndrome therapy after it achieved its primary and secondary endpoints in a Phase III study. The US ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with 68.1% of placebo comparators—resulting in a 50% relapse reduction, a ...

Chronic fatigue syndrome — also known as myalgic encephalomyelitis ... Various advocacy groups, including Solve M.E., are working to promote awareness of ME/CFS and empower people with the ...

Quoin Pharmaceuticals Ltd. announced the launch of its "Living with Netherton" video series, aimed at raising awareness about Netherton Syndrome, a poorly understood genetic disease. The first ...

Baylen Dupree and Colin Dooley find their dream apartment on TLC's "Baylen Out Loud." ...

The “Joy” bracelet—which the brand said is a “visual reminder to ‘check in’ with yourself, be fully present, and practice gratitude”—is currently on backorder “due to abundant ...

Tourette Syndrome Market: The 7 major Tourette syndrome markets reached a value of US$ 1,818.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,710.2 Million by 2034, ...